Treatment of adult's immune thrombopenia (ITP);Prise en charge du purpura thrombopénique immunologique de l'adulte

Revue de Medecine Interne

Volumn 31, Issue SUPPL. 3, 2010, Pages

  Khellaf, M ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Immune thrombopenia; Thrombopenia; Treatment

Indexed keywords

PREDNISONE; ANTIESTROGEN; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; ALGORITHM; DRUG COMBINATION; SPLENECTOMY; TREATMENT OUTCOME;

ADULT; ALGORITHMS; ANTI-INFECTIVE AGENTS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; ESTROGEN ANTAGONISTS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; TREATMENT OUTCOME;

EID: 80053218610     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.10.006     Document Type: Article

References (16)

1. Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.
2. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386-93.
3. Godeau B., Chevret S., Varet B., Lefrere F., Zini J.M., Bassompierre F., et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002, 359:23-29.
4. Khellaf M., Michel M., Schaeffer A., Bierling P., Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 2005, 90:829-832.
5. Salama A., Rieke M., Kiesewetter H., von Depka M. Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. Ann Hematol 2009, 88:11-15.
6. Scaradavou A., Woo B., Woloski B.M., Cunningham-Rundles S., Ettinger L.J., Aledort L.M., et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997, 89:2689-2700.
7. Maloisel F., Andres E., Zimmer J., Noel E., Zamfir A., Koumarianou A., et al. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results. Am J Med 2004, 116:590-594.
8. Godeau B., Durand J.M., Roudot-Thoraval F., Tenneze A., Oksenhendler E., Kaplanski G., et al. Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases. Br J Haematol 1997, 97:336-339.
9. Arnal C., Piette J.C., Leone J., Taillan B., Hachulla E., Roudot-Thoraval F., et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 2002, 29:75-83.
10. Godeau B., Porcher R., Fain O., Lefrere F., Fenaux P., Cheze S., et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood 2008, 112:999-1004.
11. Bussel J.B., Kuter D.J., Pullarkat V., Lyons R.M., Guo M., Nichol J.L. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood 2009, 113:2161-2171.
12. Kuter D.J., Bussel J.B., Lyons R.M., Pullarkat V., Gernsheimer T.B., Senecal F.M., et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008, 371:395-403.
13. Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009, 113:1231-1240.
14. Podolanczuk A., Lazarus A.H., Crow A.R., Grossbard E., Bussel J.B. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of SYK. Blood 2009, 113:3154-3160.
15. Portielje J.E., Westendorp R.G., Kluin-Nelemans H.C., Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001, 97:2549-2554.
16. Najean Y, Rain JD, Billotey C. The site of destruction of autologous 111. In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol. 1997;97:547-50.